Stopain Migraine samples were recently distributed to 100,000 migraine sufferers through more than 1,000 doctor’s offices (533 OB/GYNS* and 637 primary care physicians to be exact!). It was the first time communicating to migraineurs via the physician’s office, and at the time, only 7-10% of the doctors had ever heard about Stopain Migraine topical pain relieving gel for migraine pain. The main attributes of an over-the-counter (OTC) migraine relief product, for both types of doctors, was that it has to be safe, fast and effective.
While we expected to receive positive feedback, we were overwhelmed by the doctor positivity. Here is just some of the great physician feedback:
OB/GYNS* (67% are regularly recommending over-the-counter migraine relief products to their patients, with the additional 33% of doctors recommending some of the time):
- Safety of product was a key attribute to OB/GYNs
- In just a few week s of receiving the Stopain Migraine samples and information, 43% of the OB/GYNS have already recommended Stopain Migraine (similar to the rate that they recommend other popular OTC options, such as Excedrin Migraine) to their patients
- For pregnant patients, specifically, 22% of the OB/GYNs* had already recommended Stopain Migraine
- Now that they’ve learned about Stopain Migraine, 93% – 9 out of 10 OB/GYNS – are likely to recommend Stopain Migraine to patients
- 31% of OB/GYNS said they’d recommend Stopain Migraine in place of what their patients were currently using (with an additional 52% of OB/GYNS saying they’d swap out other medications with Stopain Migraine for some patients)
- 67% of OB/GYNs would recommend using Stopain Migraine in conjunction with other medications using to help relieve migraine pain
*Though OB/GYNs were part of the doctor feedback survey, please check with your own OB/GYN before using Stopain Migraine if you are pregnant or nursing.
PRIMARY CARE PHYSICIANS (45% are regularly recommending over-the-counter migraine relief products to their patients, with the additional 55% of doctors recommending some of the time):
- In just a few week s of receiving the Stopain Migraine samples and information, 39% of the primary care physicians have already recommended Stopain Migraine to their patients
- Now that they’ve learned about Stopain Migraine, 89% are likely to recommend Stopain Migraine to patients
- 29% of primary care physicians said they’d recommend Stopain Migraine in place of what their patients were currently using
- 75% of primary care physicians would recommend using Stopain Migraine in conjunction with other medications using to help relieve migraine pain
- In addition to safety and effectiveness, cost was an additional factor important to primary care physicians
While the goal was to get Stopain Migraine into the hands of migraine sufferers, having physicians embrace a non-pill alternative to migraine pain relief was a key result. Visit the Stopain Migraine website for more information and where to buy using the zip code locator, which includes CVS, Rite Aid, Walmart and Amazon.com.
OnabotulinumtoxinA (known as Botox-A or Botox) is commonly used in cosmetic dermatology procedures to block signals from the nerves to relax the muscles, softening the resulting lines particularly on the forehead, in crow’s feet and frown lines. In 2010, it gained U.S. Food and Drug Administration (FDA) approval as a migraine treatment for those who experience 15 or more migraines per month.
Botox treatments for migraines are typically given once every three months, with treatments involving 25-30 small injections at a time, with treatments spanning across a 15-month period. Doctors inject multiple doses of Botox in various points, such as the bridge of the nose, the temples, the forehead, the neck, back of the head and upper back. The expense may be covered by insurance, but it is quite costly otherwise.
While thought to be promising and still commonly used as a migraine treatment, a 2012 study in the Journal of the American Medical Association analyzed 27 trials that compared Botox to placebo and four studies that compared it to other migraine treatments. The findings? That Botox injections were not effective for preventing migraines in patients with less than 15 headaches per month, and those with more than 15 episodes a month had only two fewer migraines per month. While two few less is still less, those who opt for Botox will still need other options for migraine relief in conjuction, such as prescription pills, over-the counter options or alternative topical pain relief like Stopain Migraine. If you are thinking of getting Botox for migraines, first consult with a reputable physician and talk to others who have experienced the treatment.